{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:39:25Z","timestamp":1763037565858,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.revmed.2020.10.379","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T17:14:50Z","timestamp":1606324490000},"page":"392-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Myosites\u00a0: de la classification au diagnostic"],"prefix":"10.1016","volume":"42","author":[{"given":"F.","family":"Fer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Allenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.revmed.2020.10.379_bib0310","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.revmed.2020.10.379_bib0315","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.revmed.2020.10.379_bib0320","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.revmed.2020.10.379_bib0325","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.61.3.288","article-title":"Unicorns, dragons, polymyositis, and other mythological beasts","volume":"61","author":"Amato","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.revmed.2020.10.379_bib0330","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/BOR.0000000000000549","article-title":"Recent developments in classification criteria and diagnosis guidelines for idiopathic inflammatory myopathies","volume":"30","author":"Oldroyd","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.revmed.2020.10.379_bib0335","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.revmed.2020.10.379_bib0340","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.revmed.2020.10.379_bib0345","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/art.10358","article-title":"Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: Ethnogeographic influences in the genetics and clinical expression of myositis","volume":"46","author":"Shamim","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"21","key":"10.1016\/j.revmed.2020.10.379_bib0350","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.revmed.2020.10.379_bib0355","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23822","article-title":"Autoantibodies to cytosolic 5\u2032-nucleotidase 1A in inclusion body myositis","volume":"73","author":"Pluk","year":"2013","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.revmed.2020.10.379_bib0360","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","article-title":"Disease specificity of autoantibodies to cytosolic 5\u2032-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases","volume":"75","author":"Herbert","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.revmed.2020.10.379_bib0365","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.revmed.2013.09.001","article-title":"La myosite \u00e0 inclusions","volume":"35","author":"Benveniste","year":"2014","journal-title":"Rev Med Interne"},{"issue":"5","key":"10.1016\/j.revmed.2020.10.379_bib0370","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis: Inflammatory Myopathies","volume":"51","author":"Findlay","year":"2015","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.revmed.2020.10.379_bib0375","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: Clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.revmed.2020.10.379_bib0380","first-page":"e35","article-title":"Systemic Calcinosis in NXP2-Dermatomyositis","volume":"25","author":"Mart\u00edn","year":"2019","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"10.1016\/j.revmed.2020.10.379_bib0385","first-page":"1","article-title":"Clinical features of dermatomyositis associated with anti-MDA5\u00a0antibodies by age","author":"Yamaguchi","year":"2020","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2020.10.379_bib0390","first-page":"12","article-title":"Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer","volume":"8","author":"Boyer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.revmed.2020.10.379_bib0395","first-page":"18","article-title":"[Dermatomyositis: new antibody, new classification]","volume":"35","author":"Bolko","year":"2019","journal-title":"Med Sci MS"},{"issue":"18","key":"10.1016\/j.revmed.2020.10.379_bib0400","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory Muscle Diseases. Longo DL \u00e9diteur","volume":"372","author":"Dalakas","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.revmed.2020.10.379_bib0405","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.revmed.2020.10.379_bib0410","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-015-0277-y","article-title":"Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100\u00a0patients","volume":"10","author":"Suzuki","year":"2015","journal-title":"Orphanet J Rare Dis"},{"issue":"24","key":"10.1016\/j.revmed.2020.10.379_bib0415","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","article-title":"Human autoantibodies reactive with the signal-recognition particle","volume":"83","author":"Reeves","year":"1986","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"10.1016\/j.revmed.2020.10.379_bib0420","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.revmed.2020.10.379_bib0425","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/jnnp-2016-313166","article-title":"Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy","volume":"87","author":"Watanabe","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 8","key":"10.1016\/j.revmed.2020.10.379_bib0430","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"139","author":"Allenbach","year":"2016","journal-title":"Brain J Neurol"},{"issue":"7","key":"10.1016\/j.revmed.2020.10.379_bib0435","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.revmed.2013.09.003","article-title":"[Clinical phenotypes and prognosis of antisynthetase syndrome]","volume":"35","author":"Hervier","year":"2014","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.1016\/j.revmed.2020.10.379_bib0440","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/rheumatology\/kex021","article-title":"A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7\u00a0and anti-PL12\u00a0autoantibodies","volume":"56","author":"Pinal-Fernandez","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.revmed.2020.10.379_bib0445","doi-asserted-by":"crossref","first-page":"101503","DOI":"10.1016\/j.berh.2020.101503","article-title":"Clinical manifestations and treatment of antisynthetase syndrome","author":"Marco","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.revmed.2020.10.379_bib0450","doi-asserted-by":"crossref","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome. Miller F \u00e9diteur","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.revmed.2020.10.379_bib0455","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11926-013-0349-8","article-title":"Clinical Heterogeneity and Outcomes of Antisynthetase Syndrome","volume":"15","author":"Hervier","year":"2013","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.revmed.2020.10.379_bib0460","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.semarthrit.2011.09.008","article-title":"Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52\u00a0Antibody","volume":"41","author":"Marie","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.revmed.2020.10.379_bib0465","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal Muscle Involvement in Antisynthetase Syndrome","volume":"74","author":"Noguchi","year":"2017","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.revmed.2020.10.379_bib0470","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1\u00a0anti-tRNA-synthetase autoantibodies have worse survival than Jo-1\u00a0positive patients","volume":"73","author":"Aggarwal","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.revmed.2020.10.379_bib0475","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"Pt 9","key":"10.1016\/j.revmed.2020.10.379_bib0480","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1\u00a0antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.revmed.2020.10.379_bib0485","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.12659\/MSM.902016","article-title":"Associated Variables of Myositis in Systemic Lupus Erythematosus: A Cross-Sectional Study","volume":"23","author":"Liang","year":"2017","journal-title":"Med Sci Monit"},{"issue":"3","key":"10.1016\/j.revmed.2020.10.379_bib0490","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1212\/NXI.0000000000000452","article-title":"Symptomatic muscular sarcoidosis: Lessons from a nationwide multicenter study","volume":"5","author":"Cohen Aubart","year":"2018","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"issue":"23","key":"10.1016\/j.revmed.2020.10.379_bib0495","doi-asserted-by":"crossref","first-page":"e2068","DOI":"10.1212\/WNL.0000000000005638","article-title":"Muscular and extramuscular clinical features of patients with anti-PM\/Scl autoantibodies","volume":"90","author":"De Lorenzo","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.revmed.2020.10.379_bib0500","doi-asserted-by":"crossref","first-page":"92","DOI":"10.31138\/mjr.29.2.92","article-title":"Sj\u00f6gren Syndrome Associated with Inflammatory Muscle Diseases","volume":"29","author":"Migkos","year":"2018","journal-title":"Mediterr J Rheumatol"},{"issue":"13","key":"10.1016\/j.revmed.2020.10.379_bib0505","doi-asserted-by":"crossref","first-page":"e1416","DOI":"10.1212\/WNL.0000000000007188","article-title":"Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies","volume":"92","author":"Casal-Dominguez","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.revmed.2020.10.379_bib0510","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.nmd.2014.04.009","article-title":"Four-year longitudinal study of clinical and functional endpoints in sporadic inclusion body myositis: implications for therapeutic trials","volume":"24","author":"Hogrel","year":"2014","journal-title":"Neuromuscul Disord NMD"},{"issue":"7","key":"10.1016\/j.revmed.2020.10.379_bib0515","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2990.2012.01302.x","article-title":"Review: immune-mediated necrotizing myopathies--a heterogeneous group of diseases with specific myopathological features","volume":"38","author":"Stenzel","year":"2012","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"10.1016\/j.revmed.2020.10.379_bib0520","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/bjd.17536","article-title":"The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of\u00a0existing criteria","volume":"180","author":"Concha","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.revmed.2020.10.379_bib0525","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5114\/reum.2020.93505","article-title":"The clinical phenotype associated with antisynthetase autoantibodies","volume":"58","author":"Masiak","year":"2020","journal-title":"Reumatologia\/Rheumatology"},{"issue":"12","key":"10.1016\/j.revmed.2020.10.379_bib0530","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1007\/s10067-019-04710-2","article-title":"Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy","volume":"38","author":"Soubrier","year":"2019","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2020.10.379_bib0535","first-page":"787","article-title":"More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"56","author":"Tiniakou","year":"2017","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.revmed.2020.10.379_bib0540","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acr.22920","article-title":"Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle: Anti-SRP Autoantibodies in Myositis Patients","volume":"69","author":"Pinal-Fernandez","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.revmed.2020.10.379_bib0545","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/rheumatology\/keq153","article-title":"Anti-MDA5\u00a0and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis","volume":"49","author":"Hoshino","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2020.10.379_bib0550","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2019.00554","article-title":"Biomarkers in Inflammatory Myopathies-An Expanded Definition","volume":"10","author":"Benveniste","year":"2019","journal-title":"Front Neurol"},{"issue":"9","key":"10.1016\/j.revmed.2020.10.379_bib0555","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1002\/art.22865","article-title":"Anti-Jo-1\u00a0antibody levels correlate with disease activity in idiopathic inflammatory myopathy","volume":"56","author":"Stone","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.revmed.2020.10.379_bib0560","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jbspin.2019.01.013","article-title":"Strategy for suspected myositis","volume":"86","author":"Meyer","year":"2019","journal-title":"Joint Bone Spine"},{"issue":"Suppl_1","key":"10.1016\/j.revmed.2020.10.379_bib0565","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1148\/radiographics.20.suppl_1.g00oc18s295","article-title":"Abnormal Signal Intensity in Skeletal Muscle at MR Imaging: Patterns, Pearls, and Pitfalls","volume":"20","author":"May","year":"2000","journal-title":"RadioGraphics"},{"issue":"12","key":"10.1016\/j.revmed.2020.10.379_bib0570","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017\u00a0European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.revmed.2020.10.379_bib0575","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Pinal-Fernandez","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.revmed.2020.10.379_bib0580","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/annrheumdis-2012-202915","article-title":"Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis","volume":"73","author":"Malattia","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.revmed.2020.10.379_bib0585","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/jnnp-2014-310008","article-title":"Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement","volume":"87","author":"Goyal","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.revmed.2020.10.379_bib0590","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.26381","article-title":"Needle electromyography and histopathologic correlation in myopathies","volume":"59","author":"Sener","year":"2019","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.revmed.2020.10.379_bib0595","doi-asserted-by":"crossref","first-page":"e889","DOI":"10.1212\/WNL.0000000000008005","article-title":"Idiopathic inflammatory myopathy: Interrater variability in muscle biopsy reading","volume":"93","author":"Olivier","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.revmed.2020.10.379_bib0600","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.nmd.2010.03.014","article-title":"International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29\u00a0May 2009","volume":"20","author":"Benveniste","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.revmed.2020.10.379_bib0605","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MD.0000000000000028","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.revmed.2020.10.379_bib0305","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/jcla.21948","article-title":"A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies","volume":"30","author":"Tampoia","year":"2016","journal-title":"J Clin Lab Anal"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320307748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866320307748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:43:17Z","timestamp":1759336997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866320307748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0248866320307748"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2020.10.379","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myosites\u00a0: de la classification au diagnostic","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2020.10.379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}